Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ CKIP-1 Antibody Blocking Peptide
SDP

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Supplier:  Novus Biologicals™ NBP176238PEP

Catalog No. NBP176238E


Add to Cart

Description

Description

A blocking peptide containing 18 amino acids near the carboxy terminus of human CKIP1. Source: Synthetic (Accession #: NP_057358) The CKIP-1 Blocking Peptide has been validated for the following applications: Antibody Competition.
Specifications

Specifications

51177
Store at -20 C. Avoid freeze-thaw cycles.
This Peptide is Useful as a Blocking Peptide for NBP1-76238. For Further Blocking Peptide Related Protocol, Click Here .
PLEKHO1
0.05 mg
Synthetic
Human
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
2810052M02Rik, Casein kinase 2-interacting protein 1, C-Jun-binding protein, CK2 interacting protein 1; HQ0024c protein, CK2-interacting protein 1, CKIP1, CKIP-1 PH domain-containing family O member 1, JBP, OC120, Osteoclast maturation-associated gene 120 protein, pleckstrin homology domain containing, family O member 1, pleckstrin homology domain-containing family O member 1
CKIP-1
RUO - research use only
18 amino acids near the carboxy terminus of human CKIP1
Product Suggestions

Product Suggestions

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit